Scarica l'app Stockscreener
24.00
15.61%
3.24
Pre-mercato:
23.99
-0.01
-0.04%
Neurogene Inc Azioni (NGNE) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
8.75%
23.80
|
26.08 | 25.92 | 21.51 | 22.18 |
| Operating Income/Loss |
8.75%
-23.80
|
-26.08 | -25.92 | -21.51 | -22.18 |
| Income/Loss From Continuing Operations Before Tax |
4.83%
-20.95
|
-22.02 | -22.65 | -76.07 | -20.22 |
| Income/Loss From Continuing Operations After Tax |
4.83%
-20.95
|
-22.02 | -22.65 | -19.51 | -20.22 |
|
Net Income/Loss
|
4.83%
-20.95
|
-22.02 | -22.65 | -19.51 | -20.22 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.54%
21.17
|
21.06 | 21.00 | 0.6341 | 16.95 |
| Diluted Average Shares |
0.54%
21.17
|
21.06 | 21.00 | 0.6341 | 16.95 |
| Basic Earnings Per Share |
5.71%
-0.99
|
-1.05 | -1.08 | -0.99 | -1.19 |
| Diluted Earnings Per Share |
5.71%
-0.99
|
-1.05 | -1.08 | -0.99 | -1.19 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):